Title:
PHARMACEUTICAL COMPOSITION, COMPRISING POLMACOXIB AND PREGABALIN, FOR TREATMENT OF PAIN
Document Type and Number:
WIPO Patent Application WO/2019/190118
Kind Code:
A1
Abstract:
The present invention relates to a composite agent comprising polmacoxib and pregabalin. The present invention relates to a pharmaceutical composition and a drug or pain reliever, which each comprise the two active ingredients of polmacoxib and pregabalin and, more particularly, to a drug or pain reliever for treatment of moderately severe, acute, chronic, or neuropathic pain attributed to inflammation and various factors, an effect thereof, and a use thereof.
Inventors:
CHO JAE PYOUNG (KR)
PARK HYUNJIN (KR)
CHO JOONG MYUNG (KR)
PARK HYUNJIN (KR)
CHO JOONG MYUNG (KR)
Application Number:
PCT/KR2019/003225
Publication Date:
October 03, 2019
Filing Date:
March 20, 2019
Export Citation:
Assignee:
CRYSTALGENOMICS INC (KR)
International Classes:
A61K31/34; A61K9/10; A61K9/20; A61K9/50; A61K31/197; A61P25/00; A61P29/00
Foreign References:
| US20160008371A1 | 2016-01-14 | |||
| KR100537707B1 | 2005-12-20 | |||
| KR20040085216A | 2004-10-07 | |||
| KR20100112194A | 2010-10-18 | |||
| KR20170135163A | 2017-12-08 | |||
| KR100495389B1 | 2005-06-16 |
Other References:
CHUN SEUNG-HYUN: "[BioS] Biotech's No. 1 new drug,'Acelex', the second challenge'combination", 20 March 2017 (2017-03-20), pages 1 - 2, XP009524161, Retrieved from the Internet
"Korean Pharmacopoeia 11th edition"
See also references of EP 3777849A4
"Korean Pharmacopoeia 11th edition"
See also references of EP 3777849A4
Attorney, Agent or Firm:
KIM, Aera (KR)
Download PDF: